Why HemoClear
Current practice
Despite its broad applicability, donor blood transfusion is associated with high costs, medical complications, longer recovery time, and increased mortality.
Patient own blood
To improve patient care and to minimize the use of blood from donor blood pools, Blood Management Programs promote patients’ own blood for transfusion.
HemoClear
Collected patient shed blood is washed and filtered to capture red blood cells and platelets, while harmful agents and activated factors are filtered out.
Technology
Micro-filtration converts collected blood into high-quality autologous platelet-rich transfusion blood in a straightforward gravity-driven, bedside filtration procedure of approximately 30 minutes.
Where to use
HemoClear improves blood transfusion treatment outcomes at lower costs and offers life-saving access to transfusion blood in major surgery, trauma, and obstetrics.
About us
HemoClear B.V. offers innovative, Patient Blood Management devices for severe or life-threatening diseases with limited available or affordable treatment options.
HemoClear
The Challenge
Despite its broad applicability, allogeneic (donor) red blood cell transfusion is associated with health risks, high treatment costs, and scarcity……
The Solution
Patient Blood Management (PBM) reduces the use of donor blood. Using a patient’s own [Autologous] blood for transfusion is a valuable PBM tool…….
About Us
Mission
HemoClear is a leading medical device manufacturing company that is dedicated to pursuing innovation in the development of practical and highly effective medical devices. Our mission is to offer new and reliable solutions for treating severe or life-threatening diseases.
Team
At HemoClear we work with the best and brightest people in their field in a diverse and inclusive organization where everybody contributes, irrespective of cultural, ethnic, or religious background, gender, sexual orientation, health, and age.
Vacancies
At our company, we firmly believe that a vibrant and inclusive company culture is the foundation for success. We strive to create an environment that not only values the expertise and skills of our employees but also encourages them to share their thoughts, feelings, and suggestions openly.
HemoClear and Pennine Healthcare team up to develop and manufacture a complete ready-to-use HemoClear accessories kit. The kit contains all material to recuperate red blood cells from patient shed blood, enabling autologous blood transfusion. In this cooperation Pennine Healthcare obtained the exclusive commercial HemoClear distribution rights for the United Kingdom and Ireland.
" ["post_title"]=> string(53) "HemoClear Is Proud To Partner With Pennine Healthcare" ["post_excerpt"]=> string(18) "Lorem ipsum etc..." ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(30) "pennine-healthcare-cooperation" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-06-29 10:00:29" ["post_modified_gmt"]=> string(19) "2023-06-29 10:00:29" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(33) "https://test.hemoclear.com/?p=767" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }Sub-Saharan African countries continue to struggle with chronic, year-round blood shortages, limiting their ability to support patients and deliver on the health-related Sustainable Development Goals (SDGs).
Sub-Saharan African countries continue to struggle with chronic, year-round blood shortages, limiting their ability to support patients and deliver on the health-related Sustainable Development Goals (SDGs).
Most blood recipients in sub-Saharan African countries are children and women around the time of childbirth, so achieving the health-related SDGs depends on blood and blood product availability to reduce maternal mortality, end preventable deaths of newborn babies and children younger than 5 years, and achieve universal health coverage. Blood shortages in sub-Saharan Africa can have devastating consequences. An estimated 70% of 287 000 pregnancy-associated deaths in the world in 2020 occurred in sub-Saharan African countries, predominantly due to obstetric haemorrhage. Insufficient blood supply for transfusion contributes substantially to such maternal deaths in hospitals in sub-Saharan Africa.
Blood transfusions are also essential for managing sub-Saharan Africa's high rates of traffic accidents and childhood anaemia, which is commonly due to infections such as malaria, helminthiasis, and haemoglobinopathies. Sub-Saharan Africa is home to more than 75% of the 300 000–400 000 babies born each year globally with sickle cell disease; blood shortages contribute to 50–90% of these children dying before their fifth birthday.
As health-care systems develop in sub-Saharan African countries, we can also expect increased blood needs for advanced cancer therapies, such as transplantation and cell therapy, organ transplant, dialysis, and cardiac surgeries.
The status of blood supply in sub-Saharan Africa: barriers and health impact - The Lancet
" ["post_title"]=> string(77) "The status of blood supply in sub-Saharan Africa: barriers and health impact." ["post_excerpt"]=> string(208) "Sub-Saharan African countries continue to struggle with chronic, year-round blood shortages, limiting their ability to support patients and deliver on the health-related Sustainable Development Goals (SDGs). " ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(7) "example" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-06-29 11:16:15" ["post_modified_gmt"]=> string(19) "2023-06-29 11:16:15" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(34) "https://test.hemoclear.com/?p=5005" ["menu_order"]=> int(2) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }The status of blood supply in sub-Saharan Africa: barriers and health impact.
Sub-Saharan African countries continue to struggle with chronic, year-round blood shortages, limiting their ability to support patients and deliver on the health-related Sustainable Development Goals (SDGs).
Important research quantifies the global scarcity of life-saving donor blood. As a result an estimated 10 million patients unnecessarily suffer or die annually . This is caused by a 30 million unit donor-blood shortage, preventing life-saving treatment by blood transfusion.
With good results, the World Health Organization has been stimulating voluntary blood donations. HemoClear contributes by unlocking the use of autologous blood for re-infusion. The easy to use HemoClear filter optimizes the blood quality in a cost-efficient way.
" ["post_title"]=> string(51) "The World Is Experiencing a Critical Blood Shortage" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(4) "open" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(54) "the-world-is-experiencing-a-critical-shortage-of-blood" ["to_ping"]=> string(0) "" ["pinged"]=> string(35) " https://test.hemoclear.com/product" ["post_modified"]=> string(19) "2023-06-19 13:07:25" ["post_modified_gmt"]=> string(19) "2023-06-19 13:07:25" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(33) "https://test.hemoclear.com/?p=754" ["menu_order"]=> int(3) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "1" ["filter"]=> string(3) "raw" }